Initial Cases for Centric Medical’s Hammertoe Correction System

Centric Medical, a division of Life Spine Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology, announced that the company has successfully completed initial cases with the Hammertoe Correction System. The innovative system offers a dual threaded design and is inserted between the proximal and middle phalanges so that the opposing threads fixate on the phalangeal canal of the toe and compress the joint.
 
“Centric Medical’s Hammertoe Correction System is the latest in the rapid evolution of permanent implants to improve the results of hammertoe surgery. This outpatient procedure is quick and the Hammertoe System provides excellent fixation and compression to permanently correct hammertoe deformities. Patients no longer need to have pins sticking out the ends of their toes, eliminating the requirement for follow-up surgery,” said Dr. David Friscia of Eisenhower Medical Center in Rancho Mirage, Calif.
 
The Hammertoe Correction System is scheduled for a limited release in Q2 of 2017. The initial case follows the news of FDA clearance of Centric Medical’s Metatarsal Hemi Implant. These systems are part of a growing portfolio which includes innovative osteobiologic products, as well as the groundbreaking TARSA-LINK Stand-Alone Wedge Fixation System, the market’s first stand-alone osteotomy wedge with built-in fixation. The system was released to the market in September 2016.